2014
DOI: 10.4103/2277-9175.146377
|View full text |Cite
|
Sign up to set email alerts
|

Kefir protective effects against nicotine cessation-induced anxiety and cognition impairments in rats

Abstract: Background:Nicotine as one of the potent psychostimulant drugs is characterized by its parasympathomimetic activity. Upon the abrupt discontinuation of nicotine intake, a number of symptoms such as anxiety, depression and cognition impairment develop. Kefir as a food supplement is rich in tryptophan. In this study, we have evaluated the effects of Kefir on nicotine cessation-induced anxiety, depression and cognition impairment.Materials and Methods:Forty adult male rats were divided into four groups. All the g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 38 publications
1
14
0
1
Order By: Relevance
“…Before the tests starts, the animals were allowed to adapt themselves to the laboratory for at least 2 hr and they were used only once. All experimental procedures followed the Guidelines on Ethical Standards for investigation of experimental pain in animals ( Motaghinejad et al, 2014b ; Motaghinejad et al, 2015a ; Noori et al, 2014 ; Shojaii et al, 2015 ).…”
Section: Methodsmentioning
confidence: 99%
“…Before the tests starts, the animals were allowed to adapt themselves to the laboratory for at least 2 hr and they were used only once. All experimental procedures followed the Guidelines on Ethical Standards for investigation of experimental pain in animals ( Motaghinejad et al, 2014b ; Motaghinejad et al, 2015a ; Noori et al, 2014 ; Shojaii et al, 2015 ).…”
Section: Methodsmentioning
confidence: 99%
“…The preference for being in closed arms over the open ones was indicative of depressive behavior. [2528]…”
Section: Methodsmentioning
confidence: 99%
“…Investigations have confirmed that nicotine withdrawal syndrome after chronic administration and adaptations can cause increased anxiety and depression [1,6,7]. On the other hand, the anxiety and depression observed during nicotine withdrawal are major concerns for designing nicotine dependency treatment protocols [1,6,8,9]. Taking these concerns into account, some anxiolytic and antidepressant agents are being used alongside nicotine withdrawal syndrome management [10,11].…”
Section: Introductionmentioning
confidence: 99%